La vendita allo scoperto per Palladyne AI dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Palladyne AI. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Palladyne AI (NASDAQ:PDYN) Azioni, Report sulle vendite allo scoperto

Palladyne AI

Palladyne AI Corp is a software company focused on autonomy for robotic systems. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in a manner akin to human intelligence. AI and ML software platform empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

Palladyne AI Corp

Citigroup analyst Scott Gruber maintains Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Buy and raises the price target from $50 to $54.

News

Price Target

Analyst Ratings

Citigroup Maintains Buy on Schlumberger, Raises Price Target to $54

Shares of SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) are trading higher Tuesday following <a href="https://www.benzinga.com/pressreleases/25/01/b43097323/rekor-systems-taps-soundhound-ai-to-revolutionize-emergency-vehicle-technology-with-first-of-its-k">the announcement of a collaboration</a> with Rekor Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>).
What To know: The partnership between SoundHound AI and Rekor Systems will integrate SoundHound&#8217;s voice AI with Rekor&#8217;s vehicle recognition software, Rekor Scout, to enhance emergency vehicle technology. The goal is to create hands-free solutions for law enforcement and first responders, enabling the use of systems like automatic license plate recognition (ALPR), sirens and in-car data terminals via voice commands.
The technology will deliver real-time, voice-enabled alerts for wanted vehicles, Amber Alerts and other high-priority notifications, improving situational awareness by replacing traditional audio cues with natural language.
Initially focused on police vehicles, the solution will expand to fire trucks and ambulances. It will integrate with Mobile Data Terminals (MDTs) to allow officers to query databases, log incidents and perform tasks hands-free. Rekor Scout will also utilize existing high-resolution cameras in emergency vehicles, removing the need for additional hardware.
SoundHound CEO Keyvan Mohajer called the collaboration transformative, citing its potential to enhance safety and reduce distractions for law enforcement. Rekor leadership potentially emphasized its global relevance and role in modernizing policing technology.
SOUN Price Action: Soundhound shares were up 15.4% at $15.74 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21133947/Screenshot-2025-01-21-at-13.39.27-1024x529.png" alt="" class="wp-image-743365" style="width:548px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21133947/Screenshot-2025-01-21-at-13.39.27-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21133947/Screenshot-2025-01-21-at-13.39.27-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21133947/Screenshot-2025-01-21-at-13.39.27-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21133947/Screenshot-2025-01-21-at-13.39.27.png 1516w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/01/43108987/home-health-services-provider-brightspring-health-divests-community-living-business-for-850-million-to-focus-on-core-activities">BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities</a></li>
</ul>
Image Via Shutterstock.

Movers

REKR

SOUN

Soundhound AI Shares Are On The Rise Today: What's Going On?

Citigroup analyst Roland Shu downgrades United Microelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>) from Buy to Sell.

Downgrades

Citigroup Downgrades United Microelectronics to Sell

Bonk (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>) is rallying following a first filing for <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43105356/meme-coin-supercycle-dogecoin-trump-bonk-futures-etf-applications-filed">a Bonk ETF</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Bonk (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>)</td>
<td>&nbsp;$0.00003417&nbsp;&nbsp;</td>
<td>$2.6 billion</td>
<td>+10.5%&nbsp;</td>
<td>+25%&nbsp;</td>
</tr>
<tr>
<td>OFFICIAL TRUMP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>)</td>
<td>&nbsp;$42.39</td>
<td>$8.5 billion</td>
<td>+6%</td>
<td>+552.5%&nbsp;</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.3832</td>
<td>$56.6 billion</td>
<td>+6.9%&nbsp;</td>
<td>+7.4%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Mayne noted that BONK's price action reflects a strong push into demand, predicting it is "attempting a big reclaim."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24Bonk&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$Bonk</a> Weekly sweep into demand. Now attempting a big reclaim. <a href="https://t.co/pgDlI2r0UV">pic.twitter.com/pgDlI2r0UV</a>
&mdash; Mayne (@Tradermayne) <a href="https://twitter.com/Tradermayne/status/1881736086948589621?ref_src=twsrc%5Etfw">January 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Unipcs, known as the &#8220;BONK Guy,&#8221; elaborated on BONK's unique positioning within the Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) ecosystem. 
He argued that if Solana leads this cycle, BONK will naturally emerge as its primary meme coin. 
Factors like early ETF adoption, broad retail accessibility, and a strong low-unit bias position BONK for growth. 
Major exchanges like Robinhood, Coinbase, and Upbit already list the coin.
Unipcs further <a href="https://x.com/theunipcs/status/1881721798548492503">emphasized</a> that avoiding BONK exposure could result in a missed opportunity, given its potential for substantial returns.
Unipcs also <a href="https://x.com/theunipcs/status/1881729360731709813">highlighted</a> the explosive developments in the meme coin market within 24 hours of Donald Trump's inauguration. 
These include ETF filings, the formation of the Department of Government Efficiency (D.O.G.E), and the launch of an official website featuring Dogecoin's logo, signaling a new era for meme coins.
Statistics: BONK's valuation surged, placing it among the top 50 cryptocurrencies by market cap. 
Data from Coinglass shows that BONK's open interest spiked 17.8% in a day to $19.8 million, signaling increased trader activity and confidence.
Community News: Excitement around Trump's inauguration saw REXShares and Osprey filing for a series of crypto ETFs, including BONK, DOGE and TRUMP, amplifying optimism around BONK's future potential.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43066083/sol-has-a-50-of-flipping-ethereum-bonk-to-become-the-shiba-inu-of-solana-trader-posits">SOL Has A 50% Chance Of Flipping Ethereum, Bonk To Become The Shiba Inu Of Solana, Trader Posits</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BONK

$DOGE

$SOL

$TRUMP

Bonk Rallies 10% Following Bonk, Dogecoin, Trump Meme Coin ETF Filing

Wall Street analysts rerated Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) as the U.S. kicked in its earnings season last week.
<ul>
<li>Needham analyst Laura Martin reiterated a Buy rating on Amazon and a <a target="_blank" href="https://www.benzinga.com/quote/AMZN/analyst-ratings" rel="noreferrer noopener">$250&nbsp;price target</a>.</li>
<li>BofA Securities analyst Justin Post maintained a Buy rating on Amazon with a price target of $255.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/25/01/42983278/google-stock-boosted-by-ai-growth-cloud-expansion-and-cost-discipline-despite-doj-and-generative-ai-challenges-analyst" target="_blank" rel="noreferrer noopener">Google Stock Boosted By AI Growth, Cloud Expansion, Cost Discipline Despite DOJ And Generative AI Challenges: Analyst</a>
Needham: Martin hosted a panel of prior Amazon employees during the Needham Growth Conference. 
In answer to a question from the audience, the panelists agreed that Amazon CEO Andy Jassy is the right person to lead the company today. Amazon Web Services is both the present (i.e., high margins and high revenue growth rate) and the future (i.e., large language models and generative AI features, tools, and applications), they said.
They also agreed that Amazon&#8217;s strategy is shifting away from e-commerce and toward becoming the backbone of large language models, or LLMs. Jassy was the former founder and president of AWS.
Since Jassy became CEO, he has lowered the amount spent on long-term bets, such as the Fire Phone and Grocery, to improve near-term profitability and reallocate more resources toward AWS.
Amazon has a &#8220;debate and commit&#8221; culture. After everyone voices their disagreements, a decision is reached, and everyone commits. The downside of this culture is that challenging projects and problems never stop. If the old team cannot figure it out, new folks are rotated into that problem. Among all the panelists, they could only think of 2 projects that had ever been shut down. This inability to end risk-taking projects wastes time and resources.
Amazon has a rotational culture in which employees switch roles every 18-24 months. This rotation ensures fresh perspectives on every problem. It also redirects top talent to high-priority and difficult projects, but it risks talent burnout and high turnover rates.
One panelist argued that Amazon&#8217;s Delivery Service Partner (DSP) model, which relies on external contractors, may not be sustainable over time. Low control and high turnover among DSPs make it hard for Amazon to maintain operational excellence in last-mile delivery.
Retail operates on very thin margins, but operating efficiencies bolster its profitability over time.
Investments in automation and &#8220;hands-off-the-wheel&#8221; technology can improve margins in the future.
Ad Business is leading the industry in data collection and tying ad revenue to actual purchases on Amazon. They said it is the best Retail Media Network available today, and Martin agreed.
See Also: <a href="https://www.benzinga.com/news/global/25/01/43109835/small-caps-soar-apple-slips-treasury-yields-fall-on-trump-day-2-whats-driving-markets-tuesday">Small Caps Soar, Apple Slips, Treasury Yields Fall On Trump Day 2: What&#8217;s Driving Markets Tuesday?</a>
BofA Securities: Amazon outperformed the Nasdaq and e-commerce sector in 2024 (+44%, versus 25% for Nasdaq), aided by multiple expansions, with forward-year P/S growing to 3.1 times (versus 2.3 times at the start of 2024).
While AWS growth and Retail margin expectations have increased, Post noted AI-driven Cloud growth remains a top sector opportunity, while Retail Margin expansion can continue to drive outsized profit growth versus peers. Amazon is also relatively well positioned for the impact of US$ appreciation, which aids Cloud margins.
Post noted that the strong AI-demand cycle for AWS will drive upside in 2025. Further, Retail Margin efficiencies drive outsized profit growth for the company.
Amazon is a robotics play, which should drive a multi-year productivity cycle and reduce labor dependence, according to the analyst. The analyst also flagged a ramp in Prime Video ad dollars, further headcount cost savings from mid-level manager cuts, and online retail normalization as additional growth drivers for 2025.
Post slightly lowered his 2025 estimates for recent US$ appreciation. He lowered 2025 International Revenue by $7 billion (~5% of International revenue but just 1% of total), offset by slightly higher AWS margins. For fiscal 2025, Post estimates Revenue and EPS of $700 billion and $6.10, down from $707 billion and $6.13 prior.
Relative to large-cap peers, Post still expects more stable revenue growth in the first half of 2025 (with potential Cloud acceleration) and better margin expansion and noted Amazon as a relatively strong player in AI (Cloud revenues, robotics, R&amp;D efficiencies).
Price Action: Amazon stock is up 2.35% at $231.25 at last check Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42980720/microsoft-taps-meta-veteran-to-lead-new-coreai-division-plans-shift-from-openai-dependence" target="_blank" rel="noreferrer noopener">Microsoft Launches CoreAI Division: Ex-Meta Exec To Supercharge Copilot And AI Innovations</a></li>
</ul>
Image: Shutterstock

Reiteration

Tech

Trading Ideas

AMZN

AWS, Robotics, Prime Video Ads Fuel Amazon Growth Potential: Analysts

Investors with a lot of money to spend have taken a bullish stance on Nano Nuclear Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NNE, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 17 options trades for Nano Nuclear Energy.
This isn't normal.
The overall sentiment of these big-money traders is split between 58% bullish and 23%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $28,700, and 16, calls, for a total amount of $1,189,005.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20.0 to $35.0 for Nano Nuclear Energy over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Nano Nuclear Energy's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Nano Nuclear Energy's significant trades, within a strike price range of $20.0 to $35.0, over the past month.
<h3>Nano Nuclear Energy Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737487842_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NNE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.2</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$30.00</td>
<td>$225.0K</td>
<td>16</td>
<td>794</td>
</tr>
<tr>
<td>NNE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.4</td>
<td>$2.0</td>
<td>$2.4</td>
<td>$30.00</td>
<td>$118.5K</td>
<td>3.8K</td>
<td>3.4K</td>
</tr>
<tr>
<td>NNE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.25</td>
<td>$1.9</td>
<td>$2.25</td>
<td>$30.00</td>
<td>$112.5K</td>
<td>3.8K</td>
<td>2.3K</td>
</tr>
<tr>
<td>NNE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.0</td>
<td>$1.95</td>
<td>$2.0</td>
<td>$30.00</td>
<td>$100.0K</td>
<td>3.8K</td>
<td>1.7K</td>
</tr>
<tr>
<td>NNE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.6</td>
<td>$2.35</td>
<td>$2.45</td>
<td>$30.00</td>
<td>$98.0K</td>
<td>3.8K</td>
<td>5.8K</td>
</tr>
</tbody>
</table>

<h3>About Nano Nuclear Energy</h3>
Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer portable clean energy solutions. It is focused on four business lines as part of development-Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor; Fuel Processing Business; Fuel Fabrication Business; Fuel Transportation Business, and Nuclear Consultation Services.
After a thorough review of the options trading surrounding Nano Nuclear Energy, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Nano Nuclear Energy</h3>
<ul>
<li>Currently trading with a volume of 6,123,436, the NNE's price is up by 21.52%, now at $30.03. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 24 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Nano Nuclear Energy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Nano Nuclear Energy's Options: A Look at What the Big Money is Thinking

High-rolling investors have positioned themselves bullish on Bank of New York Mellon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in BK often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 13 options trades for Bank of New York Mellon. This is not a typical pattern.
The sentiment among these major traders is split, with 30% bullish and 30% bearish. Among all the options we identified, there was one put, amounting to $42,320, and 12 calls, totaling $9,530,843.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $55.0 to $85.0 for Bank of New York Mellon over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bank of New York Mellon's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bank of New York Mellon's significant trades, within a strike price range of $55.0 to $85.0, over the past month.
<h3>Bank of New York Mellon Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737487837_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$29.5</td>
<td>$29.2</td>
<td>$29.32</td>
<td>$55.00</td>
<td>$1.5M</td>
<td>3.3K</td>
<td>948</td>
</tr>
<tr>
<td>BK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$31.4</td>
<td>$27.8</td>
<td>$29.34</td>
<td>$55.00</td>
<td>$1.5M</td>
<td>3.3K</td>
<td>3.2K</td>
</tr>
<tr>
<td>BK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$29.4</td>
<td>$29.1</td>
<td>$29.26</td>
<td>$55.00</td>
<td>$1.4M</td>
<td>3.3K</td>
<td>2.2K</td>
</tr>
<tr>
<td>BK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$30.9</td>
<td>$27.8</td>
<td>$29.28</td>
<td>$55.00</td>
<td>$1.3M</td>
<td>3.3K</td>
<td>2.6K</td>
</tr>
<tr>
<td>BK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$29.4</td>
<td>$28.6</td>
<td>$29.26</td>
<td>$55.00</td>
<td>$1.0M</td>
<td>3.3K</td>
<td>1.6K</td>
</tr>
</tbody>
</table>

<h3>About Bank of New York Mellon</h3>
BNY Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors and delivers investment management and investment services in 35 countries and more than 100 markets. BNY Mellon is the largest global custody bank in the world, with $52.1 trillion in under custody or administration (as of September 2024), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY Mellon's asset-management division manages about $2.1 trillion in assets.
After a thorough review of the options trading surrounding Bank of New York Mellon, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Bank of New York Mellon's Current Market Status</h3>
<ul>
<li>With a volume of 1,884,543, the price of BK is up 1.48% at $84.52. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 84 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bank of New York Mellon options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

This Is What Whales Are Betting On Bank of New York Mellon

Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb.
Looking at options history for Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) we detected 26 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 61% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $407,249 and 17, calls, for a total amount of $1,998,519.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $65.0 for Bristol-Myers Squibb during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bristol-Myers Squibb's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bristol-Myers Squibb's significant trades, within a strike price range of $50.0 to $65.0, over the past month.
<h3>Bristol-Myers Squibb Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737487832_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$6.95</td>
<td>$6.75</td>
<td>$6.85</td>
<td>$55.00</td>
<td>$510.3K</td>
<td>8.7K</td>
<td>801</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.6</td>
<td>$3.55</td>
<td>$3.6</td>
<td>$55.00</td>
<td>$360.1K</td>
<td>12.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.0</td>
<td>$3.95</td>
<td>$4.0</td>
<td>$55.00</td>
<td>$263.2K</td>
<td>12.3K</td>
<td>1.6K</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$6.55</td>
<td>$6.4</td>
<td>$6.55</td>
<td>$52.50</td>
<td>$149.3K</td>
<td>1.9K</td>
<td>229</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.0</td>
<td>$3.95</td>
<td>$4.0</td>
<td>$55.00</td>
<td>$136.8K</td>
<td>12.3K</td>
<td>2.0K</td>
</tr>
</tbody>
</table>

<h3>About Bristol-Myers Squibb</h3>
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
In light of the recent options history for Bristol-Myers Squibb, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Bristol-Myers Squibb Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 4,648,166, with BMY's price up by 1.13%, positioned at $56.92.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 16 days.</li>
</ul>
<h3>Professional Analyst Ratings for Bristol-Myers Squibb</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $65.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Truist Securities persists with their Buy rating on Bristol-Myers Squibb, maintaining a target price of $65. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Bristol-Myers Squibb Options Trading: A Deep Dive into Market Sentiment

WIIM

STERIS shares are trading higher. The company announced outcomes from the ethylene oxide trial.

CHKP

Check Point Software shares are trading higher after Scotiabank raised its price target on the stock from $200 to $215.

DA Davidson analyst Linda Bolton Weiser maintains e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Buy and maintains $170 price target.

DA Davidson Maintains Buy on e.l.f. Beauty, Maintains $170 Price Target

Smurfit WestRock shares are trading higher after Truist Securities initiated coverage on the stock with a Buy rating and announced a price target of $62.

DA Davidson analyst Linda Bolton Weiser maintains WD-40 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) with a Buy and maintains $322 price target.

WDFC

DA Davidson Maintains Buy on WD-40, Maintains $322 Price Target

Amer Sports shares are trading higher after Morgan Stanley raised its price target on the stock from $19 to $27.

Deep-pocketed investors have adopted a bullish approach towards Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LRCX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 35 extraordinary options activities for Lam Research. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 60% leaning bullish and 25% bearish. Among these notable options, 16 are puts, totaling $1,579,298, and 19 are calls, amounting to $850,224.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $100.0 for Lam Research, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Lam Research's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lam Research's whale activity within a strike price range from $70.0 to $100.0 in the last 30 days. 
<h3>Lam Research Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737486987_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$12.3</td>
<td>$11.75</td>
<td>$12.05</td>
<td>$86.00</td>
<td>$389.2K</td>
<td align="right">264</td>
<td align="right">323</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$9.4</td>
<td>$9.3</td>
<td>$9.3</td>
<td>$88.00</td>
<td>$246.4K</td>
<td align="right">656</td>
<td align="right">300</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$23.85</td>
<td>$21.6</td>
<td>$22.35</td>
<td>$98.00</td>
<td>$183.2K</td>
<td align="right">171</td>
<td align="right">82</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$11.15</td>
<td>$11.05</td>
<td>$11.05</td>
<td>$90.00</td>
<td>$142.5K</td>
<td align="right">714</td>
<td align="right">135</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.0</td>
<td>$10.55</td>
<td>$11.0</td>
<td>$88.00</td>
<td>$104.5K</td>
<td align="right">169</td>
<td align="right">171</td>
</tr>
</tbody>
</table>

<h3>About Lam Research</h3>
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
After a thorough review of the options trading surrounding Lam Research, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Lam Research Standing Right Now?</h3>
<ul>
<li>With a volume of 5,213,585, the price of LRCX is up 2.33% at $82.17. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 8 days.</li>
</ul>
<h3>What Analysts Are Saying About Lam Research</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $85.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Lam Research with a target price of $75. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Lam Research, which currently sits at a price target of $82. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Lam Research with a target price of $90. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Lam Research, which currently sits at a price target of $85. 
&#x2A; An analyst from Keybanc upgraded its action to Overweight with a price target of $95. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Lam Research, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

LRCX

This Is What Whales Are Betting On Lam Research

Deep-pocketed investors have adopted a bullish approach towards Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 22 extraordinary options activities for Blackstone. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 40% leaning bullish and 40% bearish. Among these notable options, 10 are puts, totaling $630,808, and 12 are calls, amounting to $654,163.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $105.0 to $210.0 for Blackstone during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Blackstone stands at 870.71, with a total volume reaching 4,161.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Blackstone, situated within the strike price corridor from $105.0 to $210.0, throughout the last 30 days.
<h3>Blackstone Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737486982_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$4.15</td>
<td>$1.92</td>
<td>$3.95</td>
<td>$105.00</td>
<td>$158.0K</td>
<td align="right">124</td>
<td align="right">400</td>
</tr>
<tr>
<td>BX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$14.7</td>
<td>$14.65</td>
<td>$14.7</td>
<td>$170.00</td>
<td>$149.9K</td>
<td align="right">767</td>
<td align="right">102</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$4.45</td>
<td>$3.5</td>
<td>$3.82</td>
<td>$185.00</td>
<td>$114.2K</td>
<td align="right">60</td>
<td align="right">300</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$7.65</td>
<td>$7.2</td>
<td>$7.5</td>
<td>$175.00</td>
<td>$93.7K</td>
<td align="right">481</td>
<td align="right">139</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$7.55</td>
<td>$7.4</td>
<td>$7.5</td>
<td>$175.00</td>
<td>$88.5K</td>
<td align="right">481</td>
<td align="right">264</td>
</tr>
</tbody>
</table>

<h3>About Blackstone</h3>
Blackstone is the world's largest alternative-asset manager with $1.108 trillion in total asset under management, including $820.5 billion in fee-earning assets under management, at the end of September 2024. The company has four core business segments: private equity (25% of fee-earning AUM and 30% of base management fees), real estate (35% and 39%), credit and insurance (31% and 24%), and multi-asset investing (9% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).
Following our analysis of the options activities associated with Blackstone, we pivot to a closer look at the company's own performance.
<h3>Where Is Blackstone Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,366,334, the BX's price is up by 0.89%, now at $181.56. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 9 days.</li>
</ul>
<h3>What The Experts Say On Blackstone</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $181.25.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Keefe, Bruyette &amp; Woods keeps a Market Perform rating on Blackstone with a target price of $174. 
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on Blackstone, which currently sits at a price target of $192. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Equal-Weight rating on Blackstone with a target price of $180. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Blackstone, maintaining a target price of $179. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Blackstone options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Unpacking the Latest Options Trading Trends in Blackstone

Investors with a lot of money to spend have taken a bullish stance on Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CRM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 30 uncommon options trades for Salesforce.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 30%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $603,355, and 21 are calls, for a total amount of $1,598,760.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $260.0 to $430.0 for Salesforce over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Salesforce options trades today is 1233.88 with a total volume of 4,065.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Salesforce's big money trades within a strike price range of $260.0 to $430.0 over the last 30 days.
<h3>Salesforce 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737486976_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$8.35</td>
<td>$7.85</td>
<td>$8.25</td>
<td>$330.00</td>
<td>$312.6K</td>
<td>1.9K</td>
<td>1.1K</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$43.5</td>
<td>$41.8</td>
<td>$41.8</td>
<td>$340.00</td>
<td>$254.9K</td>
<td>281</td>
<td>62</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/31/25</td>
<td>$7.0</td>
<td>$6.4</td>
<td>$6.75</td>
<td>$325.00</td>
<td>$202.5K</td>
<td>376</td>
<td>786</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$8.45</td>
<td>$7.9</td>
<td>$8.1</td>
<td>$327.50</td>
<td>$145.8K</td>
<td>0</td>
<td>190</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$49.35</td>
<td>$47.4</td>
<td>$48.14</td>
<td>$330.00</td>
<td>$144.2K</td>
<td>638</td>
<td>30</td>
</tr>
</tbody>
</table>

<h3>About Salesforce</h3>
Salesforce provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Following our analysis of the options activities associated with Salesforce, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Salesforce</h3>
<ul>
<li>With a trading volume of 3,015,665, the price of CRM is up by 0.71%, reaching $326.87.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 36 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Salesforce</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $349.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Guggenheim downgraded its rating to Sell, setting a price target of $247. 
&#x2A; An analyst from TD Cowen upgraded its action to Buy with a price target of $400. 
&#x2A; Consistent in their evaluation, an analyst from Needham keeps a Buy rating on Salesforce with a target price of $400. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Salesforce with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Check Out What Whales Are Doing With CRM

LOGI

Logitech International shares are trading higher after JP Morgan raised its price target on the stock from $93 to $99.

The healthcare sector will be on watch Wednesday with a highly anticipated earnings report from Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) <a href="https://www.benzinga.com/earnings">before market open.</a> 
Earnings Estimates: Analysts expect Johnson &amp; Johnson to report fourth quarter revenue of $22.44 billion according to data <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012125&amp;t=be2bearmibe3na1">from Benzinga Pro.</a>
The company has beaten analyst estimates for revenue in two straight quarters and eight of the last 10 quarters overall.
Analysts expect the company to report fourth quarter earnings per share of $2.00, down from $2.29 in last year's fourth quarter. The company has beaten analyst estimates for earnings per share in 10 straight quarters.
Read Also: <a href="https://www.benzinga.com/general/biotech/25/01/43105398/fda-approves-johnson-johnsons-treatment-as-first-monotherapy-for-treatment-resistant-depression">FDA Approves Johnson &amp; Johnson&#8217;s Treatment As First Monotherapy For Treatment-Resistant Depression</a>
Key Items to Watch: Johnson &amp; Johnson has received several price target cuts from analysts in the last two months.
Bank of America <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">maintained a Neutral rating </a>and lowered the price target from $166 to $160. Citi maintained a Buy rating and lowered the price target from $185 to $175.
Freedom Capital Markets Chief Global Strategist Jay Woods highlighted the importance of Johnson &amp; Johnson's earnings report for the health care sector.
"The health care sector has remained under pressure and those following it are hoping JNJ can help bring it back to life," Woods wrote in a weekly <a href="https://jaywoods.substack.com/">newsletter</a>.
Woods said analysts and investors will be looking for the company's sales of key oncology drugs Darzalex and Carvykti. The market strategist also said investors and analysts will be looking for commentary on the recent acquisition of Cellular Therapies and its impact on the bottom line.
In the third quarter, Darzalex sales were up 22.9% year-over-year to $3.02 billion. Carvykti sales hit $286 million in the third quarter, up 87.6% year-over-year.
Woods highlighted the timing of the fourth-quarter results coming as shares have hit new 52-week lows recently.
"Johnson &amp; Johnson has dropped over -16% from its September peak making new 52-week lows as recently as last week. In fact, over the last 52 weeks, shares are lower by 8%."
With this being the company's fourth quarter, investors and analysts will also be looking for commentary on future guidance.
Johnson &amp; Johnson is a member of the Dow Jones Industrial Average and one of several Dow Jones stocks reporting financial results this week, putting ETFs like the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) into focus. 
JNJ Price Action: Johnson &amp; Johnson stock is up 1% to $148.43 on Tuesday versus a 52-week trading range of $140.68 to $168.85. The stock is down 9% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42747345/marjorie-taylor-green-went-christmas-shopping-for-stocks-heres-what-she-bought-before-holiday">Marjorie Taylor Greene Went Christmas Shopping For Stocks, Here&#8217;s What She Bought Before Holiday</a></li>
</ul>
Photo: Shutterstock

Previews

SPDR Dow Jones Industrial Average ETF Trust

Johnson & Johnson Q4 Preview: Can Earnings Bring Health Care 'Back To Life'?

On Tuesday, Guardant Health, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) announced that Palmetto GBA, a Medicare administrative contractor that administers the Molecular Diagnostics Services program (MolDX), granted coverage for the Guardant Reveal test to monitor for disease recurrence in patients with colorectal cancer (CRC) following <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43094950/guardant-health-receives-medicare-coverage-for-guardant-reveal-on-smart-liquid-biopsy-platform-for" rel="noreferrer noopener">curative intent therapy</a>.
Guardant Reveal, which runs on Guardant&#8217;s Smart Liquid Biopsy platform, is a blood test that uses epigenomic (methylation) analysis to detect circulating tumor DNA (ctDNA), a marker of minimal residual disease (MRD). This test predicts cancer recurrence, helping to guide clinical decisions after surgery or chemotherapy.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/10/41185292/fda-clears-exact-sciences-next-generation-colorectal-cancer-diagnostic-test" rel="noreferrer noopener">FDA Clears Exact Sciences&#8217; Next-Generation Colorectal Cancer Diagnostic Test</a>
As a result of this decision, the Guardant Reveal test is now covered for use in the CRC surveillance setting after curative intent treatment.
This represents an expansion from the prior Medicare coverage of Guardant Reveal testing for CRC only in the early post-surgical setting.
The tissue-free Guardant Reveal test uses a blood sample, in contrast to tumor-informed approaches to MRD testing, which require a healthcare provider to obtain a physical tissue specimen of the tumor.
William Blair, with an Outperform rating, sees this development as a strong <a href="https://www.benzinga.com/quote/GH/analyst-ratings" target="_blank" rel="noreferrer noopener">positive for the stock.</a>
Analyst Andrew Brackmann writes that the market reaction is justified, as reimbursement should enable the company to fully capitalize on its opportunities rather than limiting volumes to control cash burn, as it had previously.
Additionally, reimbursement and ongoing workflow improvements, which reduce costs, are expected to make Reveal gross margin positive later this year. The progress could help the company increase volumes (potentially exceeding the clinical volume growth target of 20%-plus for 2025), generate more revenue, and significantly reduce cash burn.
Price Action: GH stock is up 21.1% at $44.39 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/01/43099267/why-digital-solutions-provider-supercoms-stock-is-rising-today" target="_blank" rel="noreferrer noopener">Why Digital Solutions Provider SuperCom&#8217;s Stock Is Rising Today</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Equities

Health Care

General

Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test

09:40 EST Palladyne AI (PDYN) Corp trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-m...

Palladyne AI Corp trading halted, volatility trading pause

09:45 EST Palladyne AI (PDYN) Corp trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...

Palladyne AI Corp trading resumes

Palladyne AI's Red Cat Partnership: A Catalyst For Growth In Military Robotics

The latest update is out from Palladyne AI Corp ( ($PDYN) ). Palladyne AI Corp has finalized an amended and restated employment agreement with its ...

Palladyne AI Extends CEO Contract Through 2027

Stocks are lower midday, as Wall Street heads for its second consecutive winning year.

Stocks Lower Midday As 2024 Comes To An End

New option listings for January 8th include STKD BITCOIN & GOLD ETF (BTGD), MicroCloud Hologram Inc (HOLO), and Palladyne AI Corp (PDYN). Published...

Three new option listings on January 8th

Palladyne AI (PDYN) announced that the Company has been awarded a new contract from the Air Force Research Laboratory AFRL to migrate the Palladyne...

Palladyne gets contract from AFRL to migrate Pilot software to AI chip set

Explore today's market movers with our pre-market insights. From GEO's bullish breakout to LULU's earnings momentum, we dive deep using the 4 Pillars Framework. Don't miss key strategies and top stock picks for the day!

Maximize Your Trades: Pre-Market Insights And Key Stock Breakdowns

Discover the top stock picks for today's risk-on market, driven by light PPI data and anticipation of CPI. This article provides a macro review, detailed analyses of key trades, and swing trade opportunities, including KTOS, NBIS, ROOT, and more.

Light PPI Sparks Optimism: Today's Must-Watch Stocks

Palladyne AI (PDYN) (PDYN,PDYNW) and Red Cat Holdings (RCAT) announced the completion of the first successful flight in which multiple Teal drones ...

Palladyne, Red Cat announce successful multi-drone autonomous flight

ARBE

BAER

FTAI

HOLO

IMRX

KTOS

LULU

MIND

NBIS

NVDA

OPFI

PDYN

PDYNW

QCOM

QUIK

RCAT

ROOT

SGMO

TDOC

TRUG

Press Releases

Red Cat and Palladyne AI Partner to Embed Artificial Intelligence into Teal Drones to Enable Autonomous Operation

Palladyne AI Corp. Successfully Completes First Phase of Multi-Million-Dollar U.S. Air Force Contract

PALLADYNE AI CORP. Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placements

Palladyne AI and Red Cat Expand Partnership for Teal Drones

Thanksgiving Week Oversold Stocks to Watch: CRDL, QBTS, PRSO, RGTI & More!

Invest In The Robot Revolution With Small-Cap Stock Palladyne AI Corp.

Palladyne AI Achieves Key Milestone with First Small Drone Autonomous Tracking Flight

Global Drones Market Driven by Advancements in Technology and Soaring Demand Across Wide Range of Sectors

Palladyne AI Corp. Awarded Contract from Air Force Research Laboratory to Migrate Palladyne™ Pilot Autonomous Drone Software to Next-Generation AI Computing Chipsets

Comments

Palladyne AI

Vendite allo scoperto

Palladyne AI (NASDAQ:PDYN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO